Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy
暂无分享，去创建一个
David B. Darr | I. Wilson | J. Roach | M. Redinbo | R. Sartor | I. Wilson | S. Montgomery | M. Azcarate-Peril | J. Swann | R. Gharaibeh | W. Walton | Sean T. Bailey | S. Bultman | A. Bhatt | Benjamin C. Creekmore | M. Letertre | J. Roques | K. Biernat | S. Pellock | M. Azcárate-Peril | B. Wallace | Marine P. M. Letertre | J. Swann | B. Creekmore